Gielen Marc, Le Goff Anne, Stroebel David, Johnson Jon W, Neyton Jacques, Paoletti Pierre
Laboratoire de Neurobiologie, Ecole Normale Supérieure, CNRS, 46 rue d'Ulm, 75005 Paris, France.
Neuron. 2008 Jan 10;57(1):80-93. doi: 10.1016/j.neuron.2007.11.021.
Ionotropic glutamate receptor (iGluR) subunits contain a large N-terminal domain (NTD) that precedes the agonist-binding domain (ABD) and participates in subunit oligomerization. In NMDA receptors (NMDARs), the NTDs of NR2A and NR2B subunits also form binding sites for the endogenous inhibitor Zn(2+) ion. Although these allosteric sites have been characterized in detail, the molecular mechanisms by which the NTDs communicate with the rest of the receptor to promote its inhibition remain unknown. Here, we identify the ABD dimer interface as a major structural determinant that permits coupling between the NTDs and the channel gate. The strength of this interface also controls proton inhibition, another form of allosteric modulation of NMDARs. Conformational rearrangements at the ABD dimer interface thus appear to be a key mechanism conserved in all iGluR subfamilies, but have evolved to fulfill different functions: fast desensitization at AMPA and kainate receptors, allosteric inhibition at NMDARs.
离子型谷氨酸受体(iGluR)亚基包含一个位于激动剂结合域(ABD)之前的大的N端结构域(NTD),并参与亚基寡聚化。在N-甲基-D-天冬氨酸受体(NMDAR)中,NR2A和NR2B亚基的NTDs也形成内源性抑制剂Zn(2+)离子的结合位点。尽管这些变构位点已被详细表征,但NTDs与受体其他部分相互作用以促进其抑制的分子机制仍不清楚。在这里,我们确定ABD二聚体界面是允许NTDs与通道门之间偶联的主要结构决定因素。该界面的强度还控制质子抑制,这是NMDAR变构调节的另一种形式。因此,ABD二聚体界面处的构象重排似乎是所有iGluR亚家族中保守的关键机制,但已进化以实现不同功能:AMPA和海人藻酸受体的快速脱敏,NMDAR的变构抑制。